India Clinical-Trial Approvals Dropped to 23 Last Year From 270 In 2008
This article was originally published in PharmAsia News
In the past six years in India, the number of clinical trials approved has dropped from a high of 270 in 2008 to only 23 in 2013, illustrating a campaign of complaints by domestic and foreign drug makers about the system.
You may also be interested in...
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.
The US Medicare agency is offering more lower-cost alternative sites for 2021 surgical procedures to be covered under its OPPS and ASC final rule.